2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Radiofrequency pallidotomy for Embouchure dystonia

S. Horisawa, T. Kawamata, T. Taira (Shinjyuku, Japan)
Radiologic Biomarkers of Acute Non-Ketotic Hyperglycemic Chorea: A Systematic Review

D. Reis Carneiro, M. Sousa, F. Rodrigues, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)
Rapamycin for treating MSA: A preclinical proof of concept study

M. Lopez-Cuina, P. Guerin, E. Bezard, W. Meissner, P-O. Fernagut (Bordeaux, France)
Rapid onset hemidystonia-hemichorea in DYT 12: Is “SWAN NECK” limb deformity a clinical sign?

A. Elavarasi, V. Goyal, V. Vishnu, M. Singh, P. Srivastava MV (Puducherry, India)
Rapidly progressive ataxia caused by an undetermined paraneoplastic disorder: A case report

J. Conway, A. Feigin (New York, NY, USA)
Rare ADCY6 variants in two families with cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS)

N. Brüggemann, L. Olschewski, V. Tadic, A. Münchau, C. Helmchen, K. Lohmann (Lübeck, Germany)
Rasagiline as Adjunctive Therapy Induced Impulse Control Disorders in Parkinson’s Disease

M. Şenol, M. Kendirli (Istanbul, Turkey)
Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease

H.J. Yang, B.S. Park, J.Y. Park, E.M. Lee, S.Y. Kim, W.J. Kim, J.H. Kwon (Ulsan, Republic of Korea)
Rationale and Design of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study

K. Chaudhuri, D. Weintraub, A. Antonini, W. Robieson, M. Li, K. Chatamra, J. Benesh, M. Facheris (London, United Kingdom)
Re-emergent Tremor in Parkinson’s Disease

O. Dogu, M. Bozdag, N. Oksuz (Mersin, Turkey)
Real-World Outcomes Using a Novel Directional Lead from a Deep Brain Stimulation (DBS) Registry for Parkinson’s Disease

G. Deuschl, R. Jain, H. Scholtes, A. Wang, M. Barbe, A. Kühn, M. Pötter-Nerger, J. Volkmann, S. Paschen, J. Vesper (Kiel, Germany)
Receptivity to deep brain stimulation surgery among patients with essential tremor

A. Patel, C. Chow, V. Kakade, K. Nalamada, K. Para, S. Schaefer, D. Shah, E. Louis (New Haven, CT, USA)
Recognise and treat functional myoclonus: Case report

L. Tesolin, M. Liechti, S. Aybek (Trieste, Italy)
Recruitment of Minority populations with Parkinson’s disease at an Urban Hospital

C. Branson, S. Bissonette, T. Johnson, J. Weinberg, M. Saint-Hilaire (Boston, MA, USA)
Recurrent Ataxia in a Young Lady with Hashimoto’s Thyroiditis

I. Sarker, M. Habib, H. Rahman, A. Rizvi (Dhaka, Bangladesh)
Red cell distribution with levels in Parkinson’s disease patients

G. Ozgen Kenangil, B.C. Ari, F. Altuntas Kaya, M. Demir, F. Mayda Domac (Istanbul, Turkey)
Reduced vesicular storage of catacholamines enhance MPTP-induced death of dopaminergic neurons in locus coeruleus and olfactory bulb

K. Ma, J. Huang, L. Liu, X. Fang, Y. Xia, F. Wan, S. Yin, L. Kou, N. Xiong, T. Wang (Wuhan, China)
Reduction of neuroinflammation by selective inhibition of the N-type calcium channel is beneficial in various animal models of neurodegeneration, here in the SOD1G93A transgenic mouse model of ALS

J. Post-Schulz, A. Willuweit, V. Kogel, K. Langen, J. Kutzsche, D. Willbold (Jülich, Germany)
Referral and diagnostic time intervals from symptom onset to death in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Parkinson’s disease (PD)

D. Swallow, C. Counsell (Aberdeen, United Kingdom)
Regional homogeneity changes detected between Essential tremor with resting tremor and tremor-dominant Parkinson’s disease

J. Li, Z. Lu, X. Suo, N. Li, L. Wang, J. Peng, J. Zhang, Q. Gong, R. Peng (Chengdu, China)
Relation of asymmetry of dopamine depletion with motor or non-motor symptoms in patients with Parkinson’s disease: A pilot study

K.Y. Kwon, J.Y. Lee, K. Im (Seoul, Republic of Korea)
Relationship between Age-related Frailty and Intra-individual Variability of Reaction Time in Healthy Seniors: Implications for Parkinson’s disease

L. Lu (Guangzhou, People’s Republic of China)
Relationship between CTG repeats, Muscle Weakness and Respiratory Dysfunction in Myotonic Dystrophy Type 1

A. Hawkins, K. Abdul Razak, T. Khoo, K. Tran, R. Jackson (Meadowbrook, Australia)
Relationship between cyclooxygenase-2 gene polymorphisms and Parkinson’s disease susceptibility in Chinese Han population

M. Ye, Y. Yao, H. Gao (Nanjing, China)
Relationship between dopaminergic asymmetric degeneration and attentional resources in Parkinson’s disease

P. Ortelli, D. Ferrazzoli, V. Cian, L. Caremani, G. Madeo, G. Palamara, R. Maestri, G. Frazzitta (Gravedona ed Uniti, Italy)
Relationship between dysphagia severity and gait disturbance in Parkinson’s disease

C. Kobylecki, I. Shiderova, E. Michou (Salford, United Kingdom)
Relationship between non-motor symptom symptoms and clinical symptoms in Parkinson’s disease using “Non-Motor Symptom assessment scale for Parkinson’s disease”

T. Matsubara, K. Suzuki, H. Fujita, M. Matsubara, A. Numao, H. Sakuramoto, Y. Watanabe, T. Kadowaki, K. Hirata (Tochigi, Japan)
Relationship between Patient Global Impression of Change and other Efficacy Endpoints in Parkinson’s Disease: A post-hoc analysis from combined BIPARK-I and II

J. Ferreira, W. Poewe, O. Rascol, R. Costa, E. Arbe, J-F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Relationship of 10-Meter Walk Test to balance performance in Parkinson’s disease patients as a predictor of falls

A.P.C. Loureiro, B. Yamaguchi, V. Israel (Curitiba, Brazil)
Relationship of Vitamin D deficiency with Parkinson’s disease risk

M. Sanoeva, N. Mansurova (Bukhara, Uzbekistan)
Relationships between specific subtypes of mild cognitive impairment and grey matter atrophy in Parkinson’s disease

K. Nie, M. Mei, Y. Gao, M. Guo, B. Huang, Z. Huang, L. Wang, J. Zhao, Y. Zhang, D. Xiong, L. Wang (Guangzhou, China)
Reliability and Feasibility of Telemedicine Evaluation of Cervical Dystonia

A. Fraint, G. Pal, G. Stebbins, C. Comella (Chicago, IL, USA)
REM Sleep Behavior Disorder Associations with Parkinson’s Disease Study (RAPiDS): Initial Baseline Data

D. Barone, H. Sarva, L. Ravdin, M. Vo, A. Hanineva, M. DeGrazia, A. Krieger, N. Hellmers, C. Henchcliffe (New York, NY, USA)
REM sleep-related episodes in children with Narcolepsy type 1 after treatment with Sodium Oxybate

E. Antelmi, F. Pizza, G. Plazzi (Bologna, Italy)
Remote patient monitoring with a digital biomarker approach generates clinically distinctive and meaningful sensor feature data in Parkinson’s disease: Differential relationships with MDS-UPDRS-III, PDQ-39 and DaT-SPECT

F. Lipsmeier, K. Taylor, R. Postuma, D. Wolf, T. Kilchenmann, A. Scotland, J. Schjodt-Erkisen, W. Cheng, J. Siebourg-Polster, L. Jin, J. Soto, L. Verselis, F. Boess, M. Koller, M. Grundman, T. Kremer, C. Czech, C. Gossens, M. Lindemann (Basel, Switzerland)
Remotely supervised home-based aerobic exercise for Parkinson patients

N. vd Kolk, N. de Vries, B. Post, B. Bloem (Nijmegen, Netherlands)
Repetitive Transcranial Magnetic Stimulation Therapy is a Potential Therapeutic option for Primary Orthostatic Tremor

W. Hu, J. Legacy, A. Ferng, A. Wagle Shukla (Gainesville, FL, USA)
Reproductive factors influence on cognitive function of Parkinson’s disease in female patients-from a cross-sectional study

Y. Wu, H. Liu, R.W. Ou, Q.Q. Wei, H.F. Shang (Chengdu, People’s Republic of China)
Research on nearinfrared brain function imaging for Freezing of Gait in Parkinson’s Disease

Y. Jingjing, L. Zhanhua, C. Ming (Dalian, China)
Resistance to Parkinson’s disease among LRRK2 mutation carriers is associated with higher plasma levels of urate but not its purine precursors

M. Schwarzschild, R. Bakshi, R. Logan, M. Zorlu, X. Chen, A. Ascherio, E. Macklin (Boston, MA, USA)
Respiratory Complaints in Individuals with Spinocerebelar Ataxia Type 2

N. Mello, H. Teive (Curitiba, Brazil)
Response to botulinum toxin in adult onset lower limb dystonia

D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)
Resting state fMRI points to disparate brain network activations in early Parkinson’s disease

L. Salamanca, E. Glaab, R. Balling, G. Dooms, N. Diederich (Esch-sur-Alzette, Luxembourg)
Resting state networks abnormalities among healthy LRRK2 mutation carriers

A. Thaler, Y. Jacob, T. Gurevich, R. Helmich, B. Bloem, A. Orr-Urtreger, N. Giladi, L. Yahimovich, A. Mirelman, T. Hendler (Tel-Aviv, Israel)
Resting-state connectivity and cognitive changes in Parkinson’s disease: A four-year follow-up study

HC. Baggio, B. Segura, A. Abos, A. Campabadal, C. Uribe, A.I. Garcia-Diaz, M.J. Marti, Y. Compta, F. Valldeoriola, C. Junque (Barcelona, Spain)
Resting-state fMRI in Parkinson’s disease patients with cognitive impairment: A meta-analysis

A. Wolters, S. vd Weijer, A. Leentjens, A. Duits, H. Jacobs, M. Kuijf (Maastricht, Netherlands)
Resting-state fMRI study on drug-naive essential tremor patients with head tremor

L. Wang, N. Li, X. Suo, Z. Lu, J. Li, J. Peng, Q. Gong, R. Peng (Chengdu, Sichuan Province, China)
Restless legs syndrome as a first manifestation of cerebral stroke: Clinical analysis of 7 cases

X.J. Zhang, X.Y. Zhu, Y. Liu, E.K. Tan, Y.C. Wu (Shanghai, China)
Restless legs syndrome in Parkinson’s disease patients: a comparative study on prevalence, clinical features, motor and non-motor symptoms

S.Y. You, J.S. Lee, S.M. Jeon, Y.W. Cho (Daegu, Republic of Korea)
Restless Legs Syndrome in Pregnant Thai Women: Prevalence, Natural History, and Risk Factors

S. Panvatvanich, P. Lolekha (Pathumthani, Thailand)
Retinal and choroidal changes in autosomal recessive PD are similar to idiopathic PD

A. Colpak, A. Agin, G. Yalcin-Cakmakli, S. Kadayifcilar, A. Bilgic, B. Eldem, B. Elibol (Ankara, Turkey)
Retrospective study on a cohort of 285 PD patients: Does the side of onset influence the global clinical phenotype?

G. Lazzeri, G. Franco, E. Monfrini, E. Frattini, I. Trezzi, L. Borellini, G. Ardolino, F. Cogiamanian, A. Di Fonzo (Milano, Italy)
Return to automaticity: cortical activity during gait in Parkinson’s disease

S. Stuart, R. Morris, G. Booth, M. Mancini (Portland, OR, USA)
Reversible asymmetric parkinsonism and vertical gaze limitation as an initial manifestation of dural arteriovenous fistula

W. Yoon (Seoul, Republic of Korea)
Reversible Extrapyramidal features as unusual presentation of central pontine myelinolysis: A case report

S. El-Jaafary, A. Sabbah, S. Ahmed (Cairo, Egypt)
Review of mealtime difficulties following frontotemporal lobar degeneration

C. Lewis, A. Vogel, M. Walterfang, D. Velakoulis (Melbourne, Australia)
Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging: A Case Series from the PPMI Study

J. Massa, L. Chahine (Pittsburgh, PA, USA)
Revision of Parkinson’s disease diagnosis during a long-term follow-up

G. Coarelli, B. Garcin, E. Roze, M. Vidailhet, B. Degos (Bobigny, France)
Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)
Rivastigmine solution in the one-year treatment of Parkinson’s disease dementia and dementia with Lewy bodies

P.Y. Chiu (Changhua, Taiwan)
Role of metformin in diabetic aging female rat brain: a future therapy for neurodegenerative diseases

P. Kumar, N. Baquer (New Delhi, India)
Role of microglia in the transmission of α-syn-containing exosomes

Y. Xia, G. Zhang, J. Huang, N. Xiong, K. Ma, X. Guo, F. Wan, L. Kou, S. Yin, T. Wang (Wuhan, China)
Role of Sex on Cholinergic Activity and Attention in Parkinson’s disease

D. Martini, R. Morris, T. Madhyastha, T. Grabowski, J. Quinn, F. Horak (Portland, OR, USA)
Role of uric acid as a prognostic biomarker in Idiopathic Parkinson’s disease and Parkinson Plus Syndrome

T. Modi, M. Goyal, J. Kaur, B. Medhi (Chandigarh, India)
Rose Anthocyanins protect against Parkinson’s pathophysiology: Behavioral and biochemical changes in young Drosophila

G. Chandran, P. Chandrashekar, M. Jayaraju, J. Chauhan (Mysuru, India)
Rotenone model of Parkinson’s disease: The dosing options in mice revisited

M. Raza, N. Zehra, S. Malhi (Karachi, Pakistan)
Rotigotine protects dopaminergic neurons by targeting serotonin 1A receptors on astrocytes

M. Asanuma, I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, E. Nakayama, K. Shin, D. Yamamoto, Y. Kitamura (Okayama, Japan)

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z